Which Dose Schedule Matches Your Weight Loss Goals?
Mounjaro Wegovy Equivalent Doses: Understanding the Key Differences
When comparing Mounjaro and Wegovy equivalent doses, it's essential to understand that these prescription-only medicines follow fundamentally different escalation schedules. Wegovy starts at 0.25mg weekly for four weeks, progressing through 0.5mg, 1mg, and 1.7mg before reaching the maintenance dose of 2.4mg. Mounjaro begins at 2.5mg weekly, escalating to 5mg, 7.5mg, 10mg, and potentially 15mg for maintenance. The dosing schedules cannot be directly compared milligram-for-milligram because semaglutide and tirzepatide have different potencies and mechanisms of action.
Both medications require careful dose escalation to minimise side effects and optimise tolerability. Your prescriber will determine the most appropriate starting point and escalation schedule based on your medical history, current medications, and weight management goals. At EverydayMeds, our clinical team provides detailed guidance on both options, ensuring you understand the commitment required for each treatment pathway.
UK Online Pricing for Mounjaro Wegovy Equivalent Doses
Our transparent pricing structure makes it easy to budget for your chosen weight management medication. Wegovy pricing starts at £79.99 for the 0.25mg starter pen, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. We offer convenient bundle options including the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers can use code DOSE25.
Mounjaro pricing follows a different structure due to the higher starting doses and different escalation pattern. Both treatments represent a significant investment in your health, but our flexible payment options and bundle arrangements help make treatment more accessible. All prices include clinical assessment, prescriber review, and next-day cold-chain delivery to ensure medication integrity.
Clinical Evidence Behind Mounjaro Wegovy Equivalent Doses
The STEP clinical trial programme demonstrated Wegovy's efficacy, with participants achieving approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). These results formed the basis for MHRA approval and NICE recommendation TA875. The SURMOUNT trials for Mounjaro showed similar impressive results, though direct comparisons between trials should be interpreted cautiously due to different study designs and populations.
Both medications have been extensively studied in large-scale, randomised controlled trials involving thousands of participants. The clinical evidence supports their use as part of a comprehensive weight management approach including reduced-calorie diet and increased physical activity. Your prescriber will discuss the relevant evidence for your specific situation during the assessment process.
How Wegovy Works: The GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone produced in your intestines. When you eat, GLP-1 is normally released to signal fullness to your brain, slow gastric emptying, and help regulate blood sugar levels. Wegovy enhances these natural processes by providing a consistent, weekly dose of this hormone-like medication. The result is reduced appetite, increased feelings of fullness after smaller meals, and potential reduction in food cravings. Unlike quick-fix solutions, Wegovy works with your body's existing mechanisms to support sustainable weight management when combined with lifestyle modifications.
Streamlined Ordering Process for Mounjaro Wegovy Equivalent Doses
Our efficient three-step process makes accessing either medication straightforward and convenient. Begin with our comprehensive three-minute online clinical assessment covering your medical history, current medications, weight management goals, and treatment preferences. Your assessment is reviewed by our qualified prescribers within three working days (or 24 hours with express service), who determine the most suitable medication and starting dose for your circumstances. Once approved, your medication is dispatched via next-day cold-chain delivery, ensuring optimal storage conditions throughout transit. All Wegovy pens arrive with detailed injection instructions, dose escalation guidance, and ongoing support access through our patient portal.
Storage and Practical Considerations for Wegovy
Wegovy offers practical advantages in terms of storage flexibility compared to some alternatives. Store unopened pens in the fridge at 2-8°C, but once removed, they remain stable at room temperature below 30°C for up to six weeks. This storage advantage makes Wegovy particularly suitable for travel or situations where refrigeration isn't consistently available. The FlexTouch pen design provides accurate, easy dosing with pre-set amounts for each escalation stage. Your treatment journey begins with four weeks at 0.25mg, allowing your body to adjust gradually whilst minimising potential side effects. Each pen contains four doses, matching the weekly injection schedule perfectly.
Personalised Dose Selection: Matching Treatment to Individual Needs
The choice between Mounjaro and Wegovy equivalent doses depends on multiple individual factors that our clinical team carefully evaluates. Your medical history, including any diabetes diagnosis, previous weight management attempts, current medications, and personal preferences all influence the recommendation. Some patients may prefer Wegovy's lower starting dose and gentler escalation, whilst others might benefit from Mounjaro's different mechanism of action. Neither medication is inherently superior — the optimal choice depends entirely on your unique circumstances.
Our prescribers consider factors such as your target weight loss goals, tolerance for potential side effects, budget considerations, and long-term treatment sustainability. Both medications require ongoing commitment and work best as part of a comprehensive lifestyle approach including dietary modifications and increased physical activity. The assessment process ensures you understand the realistic expectations and requirements for your chosen treatment path.
Expert Support and Ongoing Monitoring
Purchasing either medication through EverydayMeds provides access to ongoing clinical support throughout your treatment journey. Our qualified healthcare professionals monitor your progress, adjust dosing as needed, and provide guidance on managing any side effects that may occur. Both Wegovy and Mounjaro are available through our regulated service, ensuring you receive genuine medications from licensed manufacturers. Whether you choose semaglutide or tirzepatide, our clinical team remains available to support your weight management goals with evidence-based guidance and personalised care. Start your assessment today using discount codes FIRST40 for new customers or DOSE25 for returning patients, and take the first step towards sustainable weight management with professional medical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
